Green Leaf Medical AB (Stockholm) has patented a production process for spinach-derived thylakoids, which the company claims can promote appetite suppression.
Green Leaf Medical AB (Stockholm) has patented a production process for spinach-derived thylakoids, which the company claims can promote appetite suppression.
Thylakoids are membrane-bound compartments found inside the chloroplasts of plant cells. According to Green Leaf, in vitro and in vivo studies indicate that these substances can prevent fat and carbohydrate assimilation and promote appetite reduction for at least six hours.
While the company is planning long-term studies for 2011 and 2012 and preparing for US and EU regulatory processes, Green Leaf says that it will have a market-ready product by 2012. The company continues to explore its ingredient for use in dietary supplements, functional foods, and beverages.
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.